Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: PEP-buddy in COPD: Effect on Dyspnea Severity and Mechanism of Action [NA]

View source ↗

Summary

Clinical trial update about PEP-buddy for chronic obstructive pulmonary disease evaluating its effect on dyspnea and mechanism of action; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PEP Buddy

Snippet

Sponsor: University Medical Center Groningen | Conditions: COPD | NA | Status: RECRUITING